title: Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
authors.forename: Marzia
authors.initials: M
authors.lastname: Lotrionte
authors.forename: Giovanni
authors.initials: G
authors.lastname: Palazzoni
authors.forename: Antonio
authors.initials: A
authors.lastname: Abbate
authors.forename: Eugenia
authors.initials: E
authors.lastname: De Marco
authors.forename: Eleonora
authors.initials: E
authors.lastname: Mezzaroma
authors.forename: Silvia
authors.initials: S
authors.lastname: Di Persio
authors.forename: Giacomo
authors.initials: G
authors.lastname: Frati
authors.forename: Francesco
authors.initials: F
authors.lastname: Loperfido
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Biondi-Zoccai
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D054715:Cardiotoxins / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives*; D015150:Echocardiography, Doppler / Q000592:standards; D015251:Epirubicin / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010865:Pilot Projects; D011092:Polyethylene Glycols / Q000009:adverse effects; D013318:Stroke Volume / Q000187:drug effects / Q000502:physiology
chemical_list: D000903:Antibiotics, Antineoplastic; D054715:Cardiotoxins; C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D015251:Epirubicin; D004317:Doxorubicin